ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+40.8%
5Y CAGR+33.5%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+40.8%/yr
vs +11.9%/yr prior
5Y CAGR
+33.5%/yr
Recent acceleration
Acceleration
+28.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.2x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$883.37M+43.8%
2024$614.38M+26.2%
2023$486.82M+53.9%
2022$316.38M+46.4%
2021$216.14M+3.7%
2020$208.47M+0.9%
2019$206.55M+2.5%
2018$201.58M+14.0%
2017$176.84M+37.5%
2016$128.62M-